Feed items

The Not-Very-Clear-Cut World Of Ads And Ad-Blocking

There's good and bad to the practice of blocking advertisements on the Web.

For Airbnb co-founder, sharing is a way of life

Talk about living and breathing a job. Airbnb's co-founder Nathan Blecharczyk shares his San Francisco home with travelers, he told CNBC.

Popular ad blocker’s maker pulls it from iTunes

For the last two days, Marco Arment has been the envy of the Apple iTunes store. His $3 app, "Peace," which allowed users to block all ads when they surf the Web on their iPhones, held the title of most downloaded paid app.

Volkswagen Halts Sales of Some Cars in the U.S.

Volkswagen AG has suspended sales in the U.S. of all vehicles containing its popular four-cylinder TDI engine in light of a U.S. investigation into allegations that the German auto maker manipulated emissions data to get around U.S. antipollution rules, a company spokesman said Sunday.

Dialog Semiconductor Buys Atmel in $4.4B Deal

LONDON (The Deal) -- The U.K.'s Dialog Semiconductor said on Sunday it has agreed to buy Atmel , of San Jose, Calif., for $4.4 billion.

An Oklahoma of Oil at Risk as Debt Shackles Shale Drillers

(Bloomberg) -- As much as 400,000 barrels a day of oil production is at risk as U.S. shale companies like Samson Resources Co. run out of money and are forced to slow drilling.

Cheap robots may shift car making from China to U.S.

The falling cost of intelligent robots may help repatriate some car manufacturing work away from low-cost locations like China back to factories in Germany and North America, Donald Walker, Chief Executive of auto supplier Magna told Reuters.

Less than zero: Are negative rates next for Fed?

A few central bank watchers were surprised by a new policy idea the Federal Reserve seemingly suggested: a negative interest rate.

Week Ahead: AutoZone Earnings, Key Economic Data

NEW YORK (TheStreet) -- As markets calm down from the Federal Reserve'snon-action, investors can look ahead to a number of company earnings and economic data this week.

A Huge Overnight Increase in a Drug’s Price Raises Protests

The price of the drug, called Daraprim, a standard of care for treating a life-threatening parasitic infection, went to $750 a tablet from $13.50.